Kimberly-Clark Trims FY21 Outlook - Quick Facts

While reporting financial results for the first quarter on Friday, consumer products firm Kimberly-Clark Corp. (KMB) trimmed its adjusted earnings and sales growth guidance for the full-year 2021.

For fiscal 2021, the company now projects adjusted earnings in a range of $7.30 to $7.55 per share on net sales growth of 3 to 5 percent, with organic sales growth of flat to 1 percent.

Previously, the company expected adjusted earnings in the range of $7.75 to $8.00 per share on net sales growth of 4 to 6 percent, with organic sales growth of 1 to 2 percent.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $7.75 per share on sales growth of 4.4 percent to $19.98 billion for the year. Analysts' estimates usually exclude special items.

Kimberly-Clark said it expects the global restructuring program initiated in January 2018 to be completed in 2021. As part of the program, Kimberly-Clark expects to exit or divest some low-margin businesses that generate about 1 percent of company net sales.

The company also expects total restructuring charges to be $2.0 billion to $2.1 billion pre-tax or $1.49 billion to $1.57 billion after tax. It will also generate annual pre-tax cost savings of $540 million to $560 million by the end of 2021.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The five-day holiday shopping period from Thanksgiving Day through Cyber Monday saw about 180 million Americans making in-store and online purchases, according to the National Retail Federation's Annual Thanksgiving Weekend Consumer Survey, conducted by Prosper Insights & Analytics. The shoppers spent an average of $301.27 on holiday-related purchases such as gifts, décor, apparel and toys. Biopharmaceutical company Immunome, Inc. (IMNM) announced Wednesday that it has conducted an assessment of the reported mutations in the new SARS-CoV-2 variant, Omicron (B.1.1.529). Based upon structural mapping of those mutations and activity against previous and current CDC variants of concern,... CVS Health said it has installed time delay safe technology in all 392 Illinois CVS Pharmacy locations, including those in Target stores, to help reduce organized retail crime. The installation of new safes for controlled substances are anticipated to help prevent pharmacy robberies. There is also potential for associated diversion of controlled substance medications, including opioid medications.
Follow RTT